Drug Type CAR-iNKT |
Synonyms CTH 501, CTH501 |
Target |
Action modulators |
Mechanism TAG-72 modulators(Tumor-associated glycoprotein 72 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Endometriosis | Preclinical | Australia | 01 May 2025 | |
Lung Cancer | Preclinical | Australia | 01 May 2025 | |
Ovarian Cancer | Preclinical | Australia | 01 May 2025 | |
Pancreatic Cancer | Preclinical | Australia | 01 May 2025 | |
Triple Negative Breast Cancer | Preclinical | Australia | 01 May 2025 |